Annual SG&A
$0.00$1.19B-100.00%
Summary
- Current Value
- As of today, DXCM annual SG&A is $0.00, down -100.00% on
- Historical Performance
- DXCM annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- DXCM annual SG&A is currently -100.00% below its historical high of $1.19B set on
- 3-Year Low Comparison
- DXCM annual SG&A vs 3-year low value is unknown
- Sector Comparison
- DXCM annual SG&A is higher than 39.46% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $331.40M | +8.2% | +41.3% | +109.0% | +3093.6% | |
| TTM SG&A | $7.35B | +480.0% | +683.5% | +1180.9% | +10000.0% | |
| Price | $70.25 | -11.3% | -35.2% | -20.2% | +1725.9% | |
| Annual Operating Expenses | $1.84B | +8.7% | +29.9% | +132.9% | +3614.0% | |
| Annual Operating Profit | $600.00M | +0.4% | +125.7% | +321.6% | +1409.1% | |
| Annual D&A | $217.70M | +17.0% | +113.6% | +347.0% | +9074.0% | |
| Annual Revenue | $4.03B | +11.3% | +64.7% | +173.2% | +10000.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.19B | -100.0% | |
| 5Y | $1.19B | -100.0% | |
| All | $1.19B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of DXCM?
As of today, DXCM annual SG&A is $0.00
What is 1-year change in DXCM annual SG&A?
DXCM annual SG&A is down -100.00% year-over-year
What is 3-year change in DXCM annual SG&A?
DXCM annual SG&A is down -100.00% over the past 3 years
How far is DXCM annual SG&A from its all-time high?
DXCM annual SG&A is currently -100.00% below its historical high of $1.19B set on December 31, 2023
How does DXCM annual SG&A rank versus sector peers?
DXCM annual SG&A is higher than 39.46% of companies in Healthcare sector
When is DXCM next annual earnings release?
The next annual earnings release for DXCM is on
Quarterly SG&A
$331.40M$3.40M+1.04%
Summary
- Current Value
- As of today, DXCM quarterly SG&A is $331.40M, up +1.04% on
- Historical Performance
- DXCM quarterly SG&A is up +8.16% year-over-year, and up +41.26% over the past 3 years
- All-Time High Comparison
- DXCM quarterly SG&A is currently -0.39% below its historical high of $332.70M set on
- 3-Year Low Comparison
- DXCM quarterly SG&A is +16.40% above its 3-year low of $284.70M reached on
- Sector Comparison
- DXCM quarterly SG&A is higher than 95.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $331.40M | +1.0% | +8.2% | +41.3% | +109.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $7.35B | +477.9% | +480.0% | +683.5% | +1180.9% | |
| Price | $70.25 | +6.1% | -11.3% | -35.2% | -20.2% | |
| Quarterly Operating Expenses | $504.90M | +6.0% | +14.3% | +64.2% | +105.0% | |
| Quarterly Operating Profit | $242.50M | +14.1% | +59.5% | +64.4% | +157.7% | |
| Quarterly D&A | $63.60M | +0.9% | +15.0% | +62.2% | +245.7% | |
| Quarterly Revenue | $1.21B | +4.5% | +21.6% | +57.1% | +141.4% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $331.40M | at high | |
| 3Y | $332.70M | -0.4% | |
| 5Y | $332.70M | -0.4% | |
| All | $332.70M | -0.4% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $310.10M | +6.9% | |
| 3Y | $284.70M | +16.4% | |
| 5Y | $175.90M | N/A | +88.4% |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of DXCM?
As of today, DXCM quarterly SG&A is $331.40M
What is DXCM quarterly SG&A most recent change?
DXCM quarterly SG&A was up +1.04% on September 30, 2025
What is 1-year change in DXCM quarterly SG&A?
DXCM quarterly SG&A is up +8.16% year-over-year
How far is DXCM quarterly SG&A from its all-time high?
DXCM quarterly SG&A is currently -0.39% below its historical high of $332.70M set on June 30, 2024
How does DXCM quarterly SG&A rank versus sector peers?
DXCM quarterly SG&A is higher than 95.71% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
TTM SG&A
$7.35B$720.70M+10.87%
Summary
- Current Value
- As of today, DXCM TTM SG&A is $7.35B, up +10.87% on
- Historical Performance
- DXCM TTM SG&A is up +480.02% year-over-year, and up +683.50% over the past 3 years
- All-Time High Comparison
- DXCM TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- DXCM TTM SG&A is +428.43% above its 3-year low of $1.39B reached on an earlier date
- Sector Comparison
- DXCM TTM SG&A is higher than 93.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $7.35B | +477.9% | +480.0% | +683.5% | +1180.9% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $331.40M | +1.0% | +8.2% | +41.3% | +109.0% | |
| Price | $70.25 | +6.1% | -11.3% | -35.2% | -20.2% | |
| TTM Operating Profit | $777.70M | +13.2% | +23.8% | +191.9% | +161.8% | |
| TTM D&A | $244.40M | +3.5% | +15.1% | +61.2% | +300.7% | |
| TTM Revenue | $4.52B | +5.0% | +14.2% | +61.7% | +148.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.35B | N/A | at high |
| 3Y | $7.35B | N/A | at high |
| 5Y | $7.35B | N/A | at high |
| All | $7.35B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.52B | N/A | +33.1% |
| 3Y | $1.39B | N/A | +428.4% |
| 5Y | -$2.06B | N/A | +456.0% |
| All | -$3.25B | N/A | +326.5% |
TTM SG&A History
FAQ
What is the current TTM SG&A of DXCM?
As of today, DXCM TTM SG&A is $7.35B
What is DXCM TTM SG&A most recent change?
DXCM TTM SG&A was up +10.87% on September 30, 2025
What is 1-year change in DXCM TTM SG&A?
DXCM TTM SG&A is up +480.02% year-over-year
How far is DXCM TTM SG&A from its all-time high?
DXCM TTM SG&A is currently at its all-time high
How does DXCM TTM SG&A rank versus sector peers?
DXCM TTM SG&A is higher than 93.78% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1093557/000109355725000280/0001093557-25-000280-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm